Shrink Nanotechnologies’ Biotech R&D Group Files Patent on Rapid Prototyping System for the $2.6 Billion Biochip Market

Shrink Nanotechnologies’ Biotech R&D Group Files Patent on Rapid Prototyping System for the $2.6 Billion Biochip Market
Shrink Nanotechnologies, Inc. (“Shrink”) (OTCBB: INKN), an innovative nanotechnology company developing products and licensing opportunities in the solar energy production, medical diagnostics and sensors, and biotechnology research and development tools businesses, announced today that patent applications related to its rapid prototyping system for the manufacture of microfluidic chips, or Lab …

Read more on SYS-CON Media